跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VASODRINE midodrine hydrochloride 5 mg immediate release tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
VASODRINE midodrine hydrochloride 5 mg immediate release tablet blister pack
Approved
STANDARD
VASODRINE midodrine hydrochloride 5 mg immediate release tablet blister pack
Southern XP IP Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
7b8ca0946ef8a2a4
Company
Southern XP IP Pty Ltd
Type
Standard
Approval Details
Approval Id
7b8ca0946ef8a2a4
Product Name
VASODRINE midodrine hydrochloride 5 mg immediate release tablet blister pack
Artg Id
309184
Artg Name
VASODRINE midodrine hydrochloride 5 mg immediate release tablet blister pack
Sponsor
Southern XP IP Pty Ltd
Company Detail Path
/organization/southern-xp-ip-pty-ltd
Artg Date
2019-12-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/606dd3e57507417303486ea25c1eee8e.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/848d8e5ace1f5ed05e49684122299fa9.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
7b8ca0946ef8a2a4
Type
Standard
Back to TGA Approvals